Researchers find predictive tests and early treatment delay progression of blood cell cancer
Thursday, November 6, 2008 - 18:42
in Health & Medicine
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer. They have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukemia (CLL).